ATLANTA, May 24, 2023 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether Integra LifeSciences Holdings Corporation (“Integra,” or the “Company”) (NASDAQ: IART) complied with federal securities laws. On May 23, 2023, Integra disclosed that the Company was recalling all products manufactured in its Boston facility that were distributed between March 1, 2018 and May 22, 2023, due to concerns over the level of endotoxins in its products. As a result of the global recall and manufacturing stoppage, the Company expects to incur an impairment charge of approximately $22 million. Following this news, the price of the Company’s stock dropped.
If you purchased Integra stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at [email protected] or Joshua Karr, Esq. at [email protected], call our toll-free number at (888) 508-6832, or visit our website at www.holzerlaw.com/case/Integra/ to discuss your legal rights.
Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021 and 2022, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.
CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
[email protected]
- Pineapple Energy Applauds Announcement of EPA’s $7B Solar for All Awards - April 25, 2024
- Crown Castle Highlights Actions its Board Has Implemented to Successfully Strengthen Foundation and Position Company for Long-Term Value Creation - April 25, 2024
- MidWestOne Financial Group, Inc. Reports Financial Results for the First Quarter of 2024 - April 25, 2024